Total joint arthroplasty (TJA) is one of the most cost-effective and successful interventions in medicine. There are more than 1 million TJAs performed in the United States annually [1,2]. This number is expected to increase to nearly 4 million by 2030 [3]. Prospective monitoring of these procedures is critical and can serve as an early warning system for faulty implant designs or procedures with higher than expected failure rates. Results presented based on a nationwide perspective, rather than from a single institution or multicenter trials allow for a larger sample size and national representation of procedures being performed [4].
No takes yet. Share an insight, caveat, or question.
Etkin et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: